Elicio Therapeutics (ELTX) EPS (Basic) (2020 - 2026)
Elicio Therapeutics' (ELTX) quarterly EPS (Basic) came in at -$1.21 in Q1 2026, down 44.04% YoY from -$2.16 in Q1 2025, and down 101.48% on a QoQ basis from -$0.6 in Q4 2025.
Elicio Therapeutics (ELTX) EPS (Basic) (2020 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has 7 years of EPS (Basic) data on file, last reported at -$1.21 in Q1 2026.
- Quarterly EPS (Basic) fell 44.04% year-over-year to -$1.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.63 (up 10.91% YoY) and the FY2025 annual result came in at -$2.79, up 76.51% from the prior year.
- EPS (Basic) slipped to -$1.21 in Q1 2026, from -$0.6 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.6 in Q4 2025 to a low of -$4.94 in Q1 2022.
- A 5-year average of -$1.92 and a median of -$1.67 in 2024 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 83.67% in 2022, down 139.75% in 2022.
- Tracing ELTX's EPS (Basic) over 5 years: stood at -$2.01 in 2022, then gained by 4.1% to -$1.93 in 2023, then surged by 45.57% to -$1.05 in 2024, then soared by 43.0% to -$0.6 in 2025, then tumbled by 101.48% to -$1.21 in 2026.
- The last three EPS (Basic) figures came in at -$1.21 (Q1 2026), -$0.6 (Q4 2025), and -$1.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - | -0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.81 |
| Mar 31, 2026 | -1.21 |
| Dec 31, 2025 | -0.60 |
| Sep 30, 2025 | -1.10 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -0.84 |
| Dec 31, 2024 | -1.05 |
| Sep 30, 2024 | -0.76 |
| Jun 30, 2024 | -1.67 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | -1.93 |
| Sep 30, 2023 | -2.35 |
| Jun 30, 2023 | -3.63 |
| Mar 31, 2023 | -2.71 |
| Dec 31, 2022 | -2.01 |
| Sep 30, 2022 | -3.40 |
| Jun 30, 2022 | -2.45 |
| Mar 31, 2022 | -4.94 |
| Dec 31, 2021 | 5.07 |
| Sep 30, 2021 | -13.76 |